Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
February 12, 2025 08:50 ET
|
eXoZymes Inc.
Rebranding Invizyne Technologies, Inc to eXoZymes Inc.Changing NASDAQ ticker from IZTC to EXOZIntroducing but not trademarking “exozymes” as a new scientific nomenclature Monrovia, California,...
Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
February 10, 2025 11:00 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce...
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities
November 19, 2024 09:05 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce...
Invizyne Technologies Announces Closing of Initial Public Offering
November 14, 2024 16:05 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
November 13, 2024 16:05 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce...
Invizyne Technologies Begins Trading on NASDAQ
November 13, 2024 09:05 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
November 12, 2024 10:52 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering
November 11, 2024 16:05 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
May 07, 2024 13:52 ET
|
Invizyne Technologies, Inc.
Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exits Additional industry veterans join in...
Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq
February 12, 2024 08:00 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...